FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Britta Wahren

Research Profile

Living Beings

Chemicals & Drugs

Co-author Network

Publications

TOP 3
David Hallengärd; Britta Wahren; Andreas Bråve
A truncated plasmid-encoded HIV-1 reverse transcriptase displays strong immunogenicity.
David Hallengärd; Anna-Karin Maltais; Mary Marovich; Bernard Moss; Kopek Nihlmark; Sanna Nyström; Britta Wahren; Steven E Applequist; Patricia Earl; Andreas Bråve
Immunization with multiple vaccine modalities induce strong HIV-specific cellular and humoral immune responses.
David Hallengärd; Maria G Isaguliants; Alan King; Richard Stout; Pontus Blomberg; Andreas Bråve; Jenny Enger; Britta Wahren
A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Britta Wahren (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: David Hallengärd; Britta Wahren; Andreas Bråve
A truncated plasmid-encoded HIV-1 reverse transcriptase displays strong immunogenicity.
Viral immunology 2013;26(2):163-6.
2012: David Hallengärd; Anna-Karin Maltais; Mary Marovich; Bernard Moss; Kopek Nihlmark; Sanna Nyström; Britta Wahren; Steven E Applequist; Patricia Earl; Andreas Bråve
Immunization with multiple vaccine modalities induce strong HIV-specific cellular and humoral immune responses.
Viral immunology 2012;25(5):423-32.
2012: David Hallengärd; Maria G Isaguliants; Alan King; Richard Stout; Pontus Blomberg; Andreas Bråve; Jenny Enger; Britta Wahren
A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines.
Genetic vaccines and therapy 2012;10(1):5.
2011: Muhammad Bakari; Gunnel Biberfeld; Andreas Bråve; Deus Buma; Patricia Earl; Joel Francis; Karina Godoy-Ramirez; Mohamed Janabi; Agricola Joachim; Eligius Lyamuya; Mary A Marovich; Fred Mhalu; Candida Moshiro; Charlotta Nilsson; Kisali Pallangyo; Victoria R Polonis; Merlin Robb; Said Aboud; Eric Aris; Britta Wahren; Eric Sandström
Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania.
Vaccine 2011;29(46):8417-28.
2011: Susanne E Johansson; Klas Kärre; Stephen J Kent; Erik Rollman; Ivan Stratov; Britta Wahren; Rob J Center; Amy W Chung; Bo Hejdeman; Jorma Hinkula; Louise Berg
NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
Viral immunology 2011;24(5):359-68.
2011: Lindvi Gudmundsdotter; B K Haller; D Bernasconi; Andreas Boberg; Stefano Buttò; U Edbäck; H Gaines; F Gotch; N Imami; J Lisziewicz; F Lori; Eric Sandström; Britta Wahren; Bo Hejdeman
Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial.
Vaccine 2011;29(33):5558-66.
2011: David Hallengärd; B Kristian Haller; Sarah Petersson; Andreas Boberg; Anna-Karin Maltais; Maria Isaguliants; Britta Wahren; Andreas Bråve
Increased expression and immunogenicity of HIV-1 protease following inactivation of the enzymatic activity.
Vaccine 2011;29(4):839-48.
2011: Susanne E Johansson; Britta Wahren; Louise Berg; Hanna Brauner; Jorma Hinkula; MH Johansson
Accumulation and activation of natural killer cells in local intraperitoneal HIV-1/MuLV infection results in early control of virus infected cells.
Cellular immunology 2011;272(1):71-8.
2011: Sarah Brinckmann; Kelly da Costa; Marit J van Gils; David Hallengärd; Katja Klein; Luisa Madeira; Lara Mainetti; Paolo Palma; Katharina Raue; David Reinhart; Marc Reudelsterz; Nicolas Ruffin; Janna Seifried; Katrein Schäfer; Enas Sheik-Khalil; Annette Sköld; Hannes Uchtenhagen; Nicolas Vabret; Serena Ziglio; Gabriella Scarlatti; Robin Shattock; Britta Wahren; Frances Gotch
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010.
Journal of translational medicine 2011;9():40.
2010: Andreas Bråve; Lindvi Gudmundsdotter; Eric Sandström; B Kristian Haller; David Hallengärd; Anna-Karin Maltais; Alan D King; Richard R Stout; Pontus Blomberg; Urban Höglund; Bo Hejdeman; Gunnel Biberfeld; Britta Wahren
Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation.
Vaccine 2010;28(51):8203-9.
2010: Said Aboud; Charlotta Nilsson; Katarina Karlén; Mary Marovich; Britta Wahren; Eric Sandström; Hans Gaines; Gunnel Biberfeld; Karina Godoy-Ramirez
Strong HIV-specific CD4+ and CD8+ T-lymphocyte proliferative responses in healthy individuals immunized with an HIV-1 DNA vaccine and boosted with recombinant modified vaccinia virus ankara expressing HIV-1 genes.
Clinical and vaccine immunology : CVI 2010;17(7):1124-31.
2010: Andreas Brave; Ulrika Johansson; David Hallengärd; SHIRIN HEIDARI; Hanna Gullberg; Britta Wahren; Jorma Hinkula; Anna-Lena Spetz
Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytes.
Vaccine 2010;28(9):2080-7.
2010: Elizaveta Starodubova; Andreas Boberg; Alexander Ivanov; Oleg Latyshev; Natalia Petrakova; Yulia Kuzmenko; Marina Litvina; Alexander Chernousov; Sergey Kochetkov; Vadim Karpov; Britta Wahren; Maria G Isaguliants
Potent cross-reactive immune response against the wild-type and drug-resistant forms of HIV reverse transcriptase after the chimeric gene immunization.
Vaccine 2010;28(8):1975-86.
2010: Susanne E Johansson; Bo Hejdeman; Jorma Hinkula; MH Johansson; François Romagné; Britta Wahren; Nicolai R Wagtmann; Klas Kärre; Louise Berg
NK cell activation by KIR-binding antibody 1-7F9 and response to HIV-infected autologous cells in viremic and controller HIV-infected patients.
Clinical immunology (Orlando, Fla.) 2010;134(2):158-68.
2009: Jorma Hinkula; Lilian Walther-Jallow; Anna Laurén; Barbro Mäkitalo; Monica Oberg; Britta Wahren; Eva-Maria Fenyö; Anna-Lena Spetz
Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells.
Vaccine 2009;27(46):6424-31.
2009: Lindvi Gudmundsdotter; Charlotta Nilsson; Andreas Brave; Bo Hejdeman; Patricia Earl; Bernard Moss; Merlin Robb; Josephine Cox; Nelson Michael; Mary Marovich; Gunnel Biberfeld; Eric Sandström; Britta Wahren
Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity.
Vaccine 2009;27(33):4468-74.
2009: Andreas Bråve; David Hallengärd; Lindvi Gudmundsdotter; Richard Stout; Richard Walters; Britta Wahren; Kristian Hallermalm
Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
Vaccine 2009;27(28):3692-6.
2009: Gerrit Koopman; Daniella Mortier; Sam Hofman; Marguerite Koutsoukos; Willy M J M Bogers; Britta Wahren; Gerald Voss; Jonathan Luke Heeney
Acute-phase CD4+ T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian-human immunodeficiency virus strain 89.6p-infected macaques.
The Journal of general virology 2009;90(Pt 4):915-26.
2009: Anna-Karin Roos; Fredrik Eriksson; James A Timmons; Josefine Gerhardt; Ulrika Nyman; Lindvi Gudmundsdotter; Andreas Bråve; Britta Wahren; Pavel Pisa
Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment.
PloS one 2009;4(9):e7226.
2008: Eric Sandström; Charlotta Nilsson; Bo Hejdeman; Andreas Bråve; Göran Bratt; Merlin Robb; Josephine Cox; Thomas Vancott; Mary Marovich; Richard Stout; Said Aboud; Muhammad Bakari; Kisali Pallangyo; Karl Ljungberg; Bernard Moss; Patricia Earl; Nelson Michael; Deborah Birx; Fred Mhalu; Britta Wahren; Gunnel Biberfeld
Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara.
The Journal of infectious diseases 2008;198(10):1482-90.
2008: Andreas Boberg; S Gaunitz; Andreas Bråve; Britta Wahren; N Carlin
Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin.
Vaccine 2008;26(40):5079-82.
2008: Jorma Hinkula; Marie Hagbom; Britta Wahren; Ulf Schroder
Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice.
Vaccine 2008;26(40):5101-6.
2008: Lindvi Gudmundsdotter; D Bernasconi; Bo Hejdeman; E Sandstrom; Annette Alaeus; Knut Lidman; Barbara Ensoli; Britta Wahren; S Buttò
Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles.
Vaccine 2008;26(40):5182-7.
2008: Paolo Palma; Maria Luisa Romiti; Caterina Cancrini; Simone Pensieroso; Carla Montesano; Stefania Bernardi; Massimo Amicosante; Silvia Di Cesare; Guido Gattinara Castelli; Britta Wahren; Paolo Rossi
Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants.
Vaccine 2008;26(40):5196-201.
2008: Elizaveta Starodubova; Andreas Boberg; Marina Litvina; Alexey Morozov; Natalia V Petrakova; Andrey Timofeev; Oleg Latyshev; Vera Tunitskaya; Britta Wahren; Maria G Isaguliants; Vadim L Karpov
HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1/Th2-type immune response.
Vaccine 2008;26(40):5170-6.
2008: Lindvi Gudmundsdotter; Ann-Charlotte Boström; Catherine Burton; Guglielmo Rosignoli; Eric Sandström; Bo Hejdeman; Britta Wahren; Nesrina Imami; Frances Gotch
Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization.
Vaccine 2008;26(40):5107-10.
2008: Andreas Bråve; David Hallengärd; Ulf Schröder; Pontus Blomberg; Britta Wahren; Jorma Hinkula
Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.
Vaccine 2008;26(40):5075-8.
2008: Johan Ingvarsson; Christer Wingren; Anders Carlsson; Peter Ellmark; Britta Wahren; Gunnel Engström; Ulrika Harmenberg; Morten Krogh; Carsten Peterson; Carl A K Borrebaeck
Detection of pancreatic cancer using antibody microarray-based serum protein profiling.
Proteomics 2008;8(11):2211-9.
2008: Andreas Boberg; Andreas Bråve; Susanne Johansson; Britta Wahren; Jorma Hinkula; Erik Rollman
Murine models for HIV vaccination and challenge.
Expert review of vaccines 2008;7(1):117-30.
2008: Gerrit Koopman; Daniella Mortier; Sam Hofman; Nathalie Mathy; Marguerite Koutsoukos; Peter Ertl; Phil Overend; CA van Wely; Lindy L Thomsen; Britta Wahren; Gerald Voss; Jonathan Luke Heeney
Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combination.
The Journal of general virology 2008;89(Pt 2):540-53.
2007: Andreas Bråve; Jorma Hinkula; Aurelio Aurelio Cafaro; Lars E Eriksson; Indresh K Srivastava; Mauro Magnani; Barbara Ensoli; Susan W Barnett; Britta Wahren; Erik Rollman
Candidate HIV-1 gp140DeltaV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge.
Vaccine 2007;25(39-40):6882-90.
2007: Andreas Bråve; Andreas Boberg; Lindvi Gudmundsdotter; Erik Rollman; Kristian Hallermalm; Karl Ljungberg; Pontus Blomberg; Richard Stout; Staffan Paulie; Eric Sandström; Gunnel Biberfeld; Patricia Earl; Bernard Moss; Josephine H Cox; Britta Wahren
A new multi-clade DNA prime/recombinant MVA boost vaccine induces broad and high levels of HIV-1-specific CD8(+) T-cell and humoral responses in mice.
Molecular therapy : the journal of the American Society of Gene Therapy 2007;15(9):1724-33.
2007: Luigi Buonaguro; Claudia Devito; Maria Lina Tornesello; Ulf Schröder; Britta Wahren; Jorma Hinkula; Franco M Buonaguro
DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.
Vaccine 2007;25(32):5968-77.
2007: Kristian Hallermalm; Susanne Johansson; Andreas Bråve; M Ek; G Engström; Andreas Boberg; Lindvi Gudmundsdotter; Pontus Blomberg; Håkan Mellstedt; Richard Stout; M A Liu; Britta Wahren
Pre-clinical evaluation of a CEA DNA prime/protein boost vaccination strategy against colorectal cancer.
Scandinavian journal of immunology 2007;66(1):43-51.
2007: Erik Rollman; Nathalie Mathy; Andreas Bråve; Andreas Boberg; Anne Kjerrström; Cathy van Wely; Gunnel Engström; Susanne Johansson; Kajsa Aperia; Lars E Eriksson; Reinhold Benthin; Peter Ertl; Jonathan Luke Heeney; Jorma Hinkula; Gerald Voss; Britta Wahren
Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
Vaccine 2007;25(11):2145-54.
2007: Andreas Bråve; Lindvi Gudmundsdotter; Georg Gasteiger; Kristian Hallermalm; Wolfgang Kastenmuller; Erik Rollman; Andreas Boberg; Gunnel Engström; Sven Reiland; Antonio Cosma; Ingo Drexler; Jorma Hinkula; Britta Wahren; Volker Erfle
Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: study of immunological memory and long-term toxicology.
Infectious agents and cancer 2007;2():14.
2007: Susanne Johansson; Monica Ek; Britta Wahren; Richard Stout; Margaret Liu; Kristian Hallermalm
Intracellular targeting of CEA results in Th1-type antibody responses following intradermal genetic vaccination by a needle-free jet injection device.
TheScientificWorldJournal 2007;7():987-99.
2007: Andreas Boberg; Sabrina Dominici; Andreas Brave; Kristian Hallermalm; Jorma Hinkula; Mauro Magnani; Britta Wahren
Immunization with HIV protease peptides linked to syngeneic erythrocytes.
Infectious agents and cancer 2007;2():9.
2007: Andreas Bråve; Karl Ljungberg; Britta Wahren; Margaret A Liu
Vaccine delivery methods using viral vectors.
Molecular pharmaceutics 2007;4(1):18-32.
2006: Lindvi Gudmundsdotter; Anna Sjödin; Ann-Charlotte Boström; Bo Hejdeman; Rebecca Theve-Palm; Annette Alaeus; Knut Lidman; Britta Wahren
Therapeutic immunization for HIV.
Springer seminars in immunopathology 2006;28(3):221-30.
2006: Susanne Johansson; David M Goldenberg; Gary L Griffiths; Britta Wahren; Jorma Hinkula
Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody.
AIDS (London, England) 2006;20(15):1911-5.
2006: Andreas Boberg; Dan Sjöstrand; Erik Rollman; Jorma Hinkula; Bartek Zuber; Britta Wahren
Immunological cross-reactivity against a drug mutated HIV-1 protease epitope after DNA multi-CTL epitope construct immunization.
Vaccine 2006;24(21):4527-30.
2006: Elizaveta Starodubova; Andreas Boberg; Elena Kashuba; Britta Wahren; Vadim Karpov; Maria G Isaguliants
HIV-1 reverse transcriptase targeted for proteasomal degradation as a prototype vaccine against drug-resistant HIV-1.
Vaccine 2006;24(21):4541-7.
2006: Andreas Bråve; Karl Ljungberg; Andreas Boberg; Erik Rollman; Gunnel Engström; Jorma Hinkula; Britta Wahren
Reduced cellular immune responses following immunization with a multi-gene HIV-1 vaccine.
Vaccine 2006;24(21):4524-6.
2006: Jorma Hinkula; Claudia Devito; Bartek Zuber; Reinhold Benthin; Denise Ferreira; Britta Wahren; Ulf Schröder
A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations.
Vaccine 2006;24(21):4494-7.
2006: Elin Kindberg; Bo Hejdeman; Göran Bratt; Britta Wahren; Bertil Lindblom; Jorma Hinkula; Lennart Svensson
A nonsense mutation (428G-->A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection.
AIDS (London, England) 2006;20(5):685-9.
2006: Jonas Klingström; Lindvi Gudmundsdotter; Bartek Zuber; Jorma Hinkula; Andreas Mörner; Britta Wahren; Erik Rollman
Elevated levels of serum perforin in chronic HIV-1 and acute SIV/SHIV infection.
AIDS (London, England) 2006;20(1):125-7.
2006: Reikei Matsuda; Ann-Charlotte Boström; Malin Fredriksson; Eva-Lena Fredriksson; Göran Bratt; Bo Hejdeman; Eric Sandström; Kenji Okuda; Britta Wahren
Human immunodeficiency virus-type 1 specific cellular immunity in chronic infected patients on prolonged highly active antiretroviral treatment and on structured treatment interruption.
Microbiology and immunology 2006;50(8):629-35.
2006: Maria K Jonsson; Michael Levi; Ulla Rudén; Britta Wahren
Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study.
Scandinavian journal of infectious diseases 2006;38(5):357-65.
2005: Andreas Bråve; Karl Ljungberg; Andreas Boberg; Erik Rollman; Maria G Isaguliants; Björn Lundgren; Pontus Blomberg; Jorma Hinkula; Britta Wahren
Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;12(6):1197-205.
2005: Erik Rollman; Andreas Bråve; Andreas Boberg; Lindvi Gudmundsdotter; Gunnel Engström; Maria G Isaguliants; Karl Ljungberg; B Lundgren; Pontus Blomberg; Jorma Hinkula; Bo Hejdeman; Eric Sandström; Margaret Liu; Britta Wahren
The rationale behind a vaccine based on multiple HIV antigens.
Microbes and infection / Institut Pasteur 2005;7(14):1414-23.
2005: Maria Malm; Erik Rollman; Mart Ustav; Jorma Hinkula; Kai Krohn; Britta Wahren; Vesna Blazevic
Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.
Viral immunology 2005;18(4):678-88.
2005: Joacim Elmén; Håkan Thonberg; Karl Ljungberg; Miriam Frieden; Majken Westergaard; Yunhe Xu; Britta Wahren; Zicai Liang; Henrik Ørum; Troels Koch; Claes Wahlestedt
Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality.
Nucleic acids research 2005;33(1):439-47.
2004: Joacim Elmén; Hong-Yan Zhang; Bartek Zuber; Karl Ljungberg; Britta Wahren; Claes Wahlestedt; Zicai Liang
Locked nucleic acid containing antisense oligonucleotides enhance inhibition of HIV-1 genome dimerization and inhibit virus replication.
FEBS letters 2004;578(3):285-90.
2004: Claudia Devito; Bartek Zuber; Ulf Schröder; Reinhold Benthin; Kenji Okuda; Kristina Broliden; Britta Wahren; Jorma Hinkula
Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(11):7078-89.
2004: Bo Hejdeman; Ann-Charlotte Boström; R Matsuda; SA Calarota; R Lenkei; Eva Lena Fredriksson; Eric Sandström; Göran Bratt; Britta Wahren
DNA immunization with HIV early genes in HIV type 1-infected patients on highly active antiretroviral therapy.
AIDS research and human retroviruses 2004;20(8):860-70.
2004: Barbro Mäkitalo; Peter Lundholm; Jorma Hinkula; Charlotta Nilsson; Katarina Karlén; Andreas Mörner; Gerd Sutter; Volker Erfle; Jonathan Luke Heeney; Britta Wahren; Gunnel Biberfeld; Rigmor Thorstensson
Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen.
The Journal of general virology 2004;85(Pt 8):2407-19.
2004: Erik Rollman; Jorma Hinkula; J Arteaga; Bartek Zuber; Anne Kjerrström; Margaret Liu; Britta Wahren; Karl Ljungberg
Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies.
Gene therapy 2004;11(14):1146-54.
2004: Lars H Lund; Karl Ljungberg; Britta Wahren; Jorma Hinkula
Primary murine cells as a model for HIV-1 infection.
AIDS (London, England) 2004;18(7):1067-9.
2004: Erik Rollman; Lisen Arnheim; Brian Collier; Daniel Oberg; Håkan Hall; Jonas Klingström; Joakim Dillner; Diana V Pastrana; Christopher B Buck; Jorma Hinkula; Britta Wahren; Stefan Schwartz
HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses.
Virology 2004;322(1):182-9.
2004: Maria G Isaguliants; Bartek Zuber; Andreas Boberg; Dan Sjöstrand; Sergey V Belikov; Erik Rollman; Anne Kjerrström Zuber; Vladimir O Rechinsky; Ann-Sofie Rytting; Clas F R Källander; Jorma Hinkula; Sergey N Kochetkov; Margaret Liu; Britta Wahren
Reverse transcriptase-based DNA vaccines against drug-resistant HIV-1 tested in a mouse model.
Vaccine 2004;22(13-14):1810-9.
2004: Anne Kjerrström Zuber; Andreas Bråve; Gunnel Engström; Bartek Zuber; Karl Ljungberg; Malin Fredriksson; Reinhold Benthin; Maria G Isaguliants; Eric Sandström; Jorma Hinkula; Britta Wahren
Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA.
Vaccine 2004;22(13-14):1791-8.
2004: Ann-Charlotte Boström; Bo Hejdeman; Reikei Matsuda; Malin Fredriksson; Eva-Lena Fredriksson; Göran Bratt; Eric Sandström; Britta Wahren
Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).
Vaccine 2004;22(13-14):1683-91.
2004: Maria G Isaguliants; Konstantin Iakimtchouk; Natalia V Petrakova; Marina A Yermalovich; Anne Kjerrström Zuber; Vladimir I Kashuba; Sergey V Belikov; Sören Andersson; Sergey N Kochetkov; Dennis M Klinman; Britta Wahren
Gene immunization may induce secondary antibodies reacting with DNA.
Vaccine 2004;22(11-12):1576-85.
2004: Antonio Cosma; Silja Bühler; Rashmi Nagaraj; Caroline Staib; Anna-Lena Hammarin; Britta Wahren; Frank D Goebel; Volker Erfle; Gerd Sutter
Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.
Clinical and diagnostic laboratory immunology 2004;11(2):406-10.
2004: Anna Linda Hultström; Göran Bratt; Antonio Cosma; Volker Erfle; Britta Wahren; Ennio Carbone
Autologous cytotoxicity of natural killer cells derived from HIV-infected patients.
Immunology letters 2004;91(2-3):155-8.
2004: Maria G Isaguliants; Sergey V Belikov; Elizaveta Starodubova; Rinat Z Gizatullin; Erik Rollman; Bartek Zuber; Anne Kjerrström Zuber; Olga I Andreeva Grishchenko; Ann-Sofie Rytting; Clas F R Källander; Sergey N Kochetkov; Vadim L Karpov; Britta Wahren
Mutations conferring drug resistance affect eukaryotic expression of HIV type 1 reverse transcriptase.
AIDS research and human retroviruses 2004;20(2):191-201.
2004: Jorma Hinkula; Erik Rollman; Peter Lundholm; Reinhold Benthin; Kenji Okuda; Britta Wahren
Genetic immunization with multiple HIV-1 genes provides protection against HIV-1/MuLV pseudovirus challenge in vivo.
Cells, tissues, organs 2004;177(3):169-84.
2004: Maria Karolina Jonsson; Britta Wahren
Sexually transmitted herpes simplex viruses.
Scandinavian journal of infectious diseases 2004;36(2):93-101.
2003: Erik Rollman; Torbjörn Ramqvist; Bartek Zuber; Karin Tegerstedt; A Kjerrström Zuber; Jonas Klingström; L Eriksson; Karl Ljungberg; Jorma Hinkula; Britta Wahren; Tina Dalianis
Genetic immunization is augmented by murine polyomavirus VP1 pseudocapsids.
Vaccine 2003;21(19-20):2263-7.
2003: Lars E Eriksson; Thomas Leitner; Britta Wahren; Aaa-Charlotte Bostrom; Kerstin I Falk
A multiplex real-time PCR for quantification of HIV-1 DNA and the human albumin gene in CD4+ cells.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(6):625-33.
2003: Lars H Lund; Karolina Andersson; Bartek Zuber; Anneli Karlsson; Gunnel Engström; Jorma Hinkula; Britta Wahren; Gösta Winberg
Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system.
Cancer gene therapy 2003;10(5):365-76.
2003: Lars E Eriksson; Kerstin I Falk; Göran Bratt; Ann-Charlotte Boström; Britta Wahren; Thomas Leitner
HIV type 1 DNA development during long-term supervised therapy interruption.
AIDS research and human retroviruses 2003;19(4):259-65.
2003: Bo Hejdeman; Ann-Charlotte Boström; Eva Lena Fredriksson; Eric Sandström; Britta Wahren; G Bratt
Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up.
HIV medicine 2003;4(2):101-10.
2003: Mehrdad Mousavi-Jazi; Lottie Schloss; Britta Wahren; Maria Brytting
Point mutations induced by foscarnet (PFA) in the human cytomegalovirus DNA polymerase.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2003;26(3):301-6.
2002: Erik Rollman; Lars H Lund; Dan E Sjöstrand; Thomas Leitner; Britta Wahren
A unique amino acid deletion in the chimpanzee Cyclin T1 does not affect Tat trans-activation of HIV.
AIDS (London, England) 2002;16(17):2335-7.
2002: Karl Ljungberg; Erik Rollman; Lars Eriksson; Jorma Hinkula; Britta Wahren
Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes.
Virology 2002;302(1):44-57.
2002: Bartek Zuber; Barbro Mäkitalo; Anne Kjerrström Zuber; Britta Wahren
A novel potent strategy for induction of immunity to HIV-1 reverse transcriptase in primates.
AIDS (London, England) 2002;16(13):1839-40.
2002: Karl Ljungberg; Mohammed Sawkat Hassan; Mohammad Nazrul Islam; Mahbub Allam Siddiqui; Mohammad Monowar Aziz; Britta Wahren; Khalid Bin Islam; Thomas Leitner
Subtypes A, C, G, and recombinant HIV type 1 are circulating in Bangladesh.
AIDS research and human retroviruses 2002;18(9):667-70.
2002: Karl Ljungberg; Camilla Kolmskog; Britta Wahren; Geert van Amerongen; Marianne Baars; Albert Osterhaus; Annika Linde; Guus F Rimmelzwaan
DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes.
Vaccine 2002;20(16):2045-52.
2002: Britta Wahren; Karl Ljungberg; Erik Rollman; M Levi; Bartek Zuber; A Kjerrström Zuber; Jorma Hinkula; Ann-Charlotte Boström; SA Calarota; Bo Hejdeman; Göran Bratt; Eric Sandström
HIV subtypes and recombination strains--strategies for induction of immune responses in man.
Vaccine 2002;20(15):1988-93.
2002: Peter Lundholm; Ann-Charlotte Boström; Birger Christensson; Göran Bratt; Eric Sandström; Britta Wahren
DNA mucosal HIV vaccine in humans.
Virus research 2002;82(1-2):141-5.
2001: Mehrdad Mousavi-Jazi; Lottie Schloss; W Lawrence Drew; Annika Linde; Richard C Miner; J Harmenberg; Britta Wahren; Maria Brytting
Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2001;23(1-2):1-15.
2001: SA Calarota; Anne Kjerrström; Khalid Bin Islam; Britta Wahren
Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
Human gene therapy 2001;12(13):1623-37.
2001: Setsuko Watabe; Ke-Qin Xin; Atsushi Ihata; L J Liu; A Honsho; I Aoki; Kenji Hamajima; Britta Wahren; Kenji Okuda
Protection against influenza virus challenge by topical application of influenza DNA vaccine.
Vaccine 2001;19(31):4434-44.
2001: Anne Kjerrström; Jorma Hinkula; Gunnel Engström; V Ovod; K Krohn; Reinhold Benthin; Britta Wahren
Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines.
Virology 2001;284(1):46-61.
2001: Bartek Zuber; D Böttiger; Reinhold Benthin; Peter Ten Haaft; Jonathan Luke Heeney; Britta Wahren; B Oberg
An in vivo model for HIV resistance development.
AIDS research and human retroviruses 2001;17(7):631-5.
2001: Bo Hejdeman; R Lenkei; Ann-Charlotte Boström; Anna Linda Hultström; Britta Wahren; Eric Sandström; Göran Bratt
Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection.
AIDS research and human retroviruses 2001;17(4):277-86.
2001: K Tadokoro; Y Koizumi; Y Miyagi; Yoshitsugu Kojima; S Kawamoto; Kenji Hamajima; Kenji Okuda; S Tanaka; K Onari; Britta Wahren; I Aoki; K Okuda
Rapid and wide-reaching delivery of HIV-1 env DNA vaccine by intranasal administration.
Viral immunology 2001;14(2):159-67.
2001: SA Calarota; Britta Wahren
Cellular HIV-1 immune responses in natural infection and after genetic immunization.
Scandinavian journal of infectious diseases 2001;33(2):83-96.
2000: Bartek Zuber; Jorma Hinkula; D Vödrös; Peter Lundholm; Charlotta Nilsson; Andreas Mörner; M Levi; Reinhold Benthin; Britta Wahren
Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge.
Virology 2000;278(2):400-11.
2000: Mehrdad Mousavi-Jazi; Vivi-Anne Sundqvist; Annika Linde; Britta Wahren; Maria Brytting
Growth phenotypes of cytomegalovirus isolates do not correlate with glycoprotein B, major immediate early genotypes or antiviral sensitivity.
Journal of medical virology 2000;62(2):117-26.
2000: Maria G Isaguliants; SO Gudima; O V Ivanova; M Levi; Jorma Hinkula; M M Garaev; Sergey N Kochetkov; Britta Wahren
Immunogenic properties of reverse transcriptase of HIV type 1 assessed by DNA and protein immunization of rabbits.
AIDS research and human retroviruses 2000;16(13):1269-80.
2000: J K Sandberg; Ann-Charlotte Boström; Claudia Devito; B Kohleisen; Volker Erfle; Adnane Achour; M Levi; S Schwartz; Klas Kärre; Britta Wahren; Jorma Hinkula
Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Virology 2000;273(1):112-9.
2000: Cristina Cerboni; Mehrdad Mousavi-Jazi; A Linde; Kalle Söderström; Maria Brytting; Britta Wahren; Klas Kärre; Ennio Carbone
Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(9):4775-82.
2000: Ann-Charlotte Boström; G Gilljam; Malin Fredriksson; Jorma Hinkula; Annette Alaeus; Knut Lidman; Jan Albert; Göran Bratt; Eric Sandström; Britta Wahren
Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1.
Journal of virology 2000;74(10):4888-90.
2000: Karl Ljungberg; Britta Wahren; J Almqvist; Jorma Hinkula; Annika Linde; Gösta Winberg
Effective construction of DNA vaccines against variable influenza genes by homologous recombination.
Virology 2000;268(2):244-50.
2000: Thomas Tolfvenstam; Malin Enbom; H Ghebrekidan; Ulla Rudén; Annika Linde; M Grandien; Britta Wahren
Seroprevalence of viral childhood infections in Eritrea.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2000;16(1):49-54.
2000: Anna Linda Hultström; Bo Hejdeman; Ann-Charlotte Boström; Göran Bratt; E Carbone; Britta Wahren
Human natural killer cells in asymptomatic human immunodeficiency virus-1 infection.
Intervirology 2000;43(4-6):294-301.
2000: Maria G Isaguliants; N N Petrakova; Bartek Zuber; Katja Pokrovskaya; Rinat Z Gizatullin; Dmitry A Kostyuk; Anne Kjerrström; Gösta Winberg; Sergey N Kochetkov; Jorma Hinkula; Britta Wahren
DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge.
Intervirology 2000;43(4-6):288-93.
2000: M Levi; Jorma Hinkula; Britta Wahren
A retro-inverso miniantibody with anti-HIV activity.
AIDS research and human retroviruses 2000;16(1):59-65.
2000: Y Asakura; L J Liu; N Shono; Jorma Hinkula; Anne Kjerrström; I Aoki; Kenji Okuda; Britta Wahren; Jun Fukushima
Th1-biased immune responses induced by DNA-based immunizations are mediated via action on professional antigen-presenting cells to up-regulate IL-12 production.
Clinical and experimental immunology 2000;119(1):130-9.
1999: Malin Enbom; Thomas Tolfvenstam; H Ghebrekidan; Ulla Rudén; M Grandien; Britta Wahren; Annika Linde
Seroprevalence of human herpes virus 8 in different Eritrean population groups.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 1999;14(3):167-72.
1999: SA Calarota; Ann-Charlotte Boström; Göran Bratt; Jorma Hinkula; D M Klinman; K J Weinhold; Eric Sandström; Britta Wahren
Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(4):2330-8.
1999: Göran Bratt; Lars E Eriksson; Eric Sandström; G Gilljam; Jorma Hinkula; Jan Albert; Robert R Redfield; Britta Wahren
Long-term immunotherapy in HIV infection, combined with short-term antiretroviral treatment.
International journal of STD & AIDS 1999;10(8):514-21.
1999: G Gilljam; A Svensson; A Ekström; Britta Wahren
Immunological responses to envelope glycoprotein 120 from subtypes of human immunodeficiency virus type 1.
AIDS research and human retroviruses 1999;15(10):899-907.
1999: Michael Levi; Ulla Rudén; H Carlberg; Britta Wahren
The use of peptides from glycoproteins G-2 and D-1 for detecting herpes simplex virus type 2 and type-common antibodies.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 1999;12(3):243-52.
1999: Peter Lundholm; Y Asakura; Jorma Hinkula; E Lucht; Britta Wahren
Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA.
Vaccine 1999;17(15-16):2036-42.
1999: Maria G Isaguliants; Katja Pokrovskaya; V I Kashuba; D Pokholok; Jorma Hinkula; Britta Wahren; Sergey N Kochetkov
Eukaryotic expression of enzymatically active human immunodeficiency virus type 1 reverse transcriptase.
FEBS letters 1999;447(2-3):232-6.
1999: Y Asakura; Peter Lundholm; Anne Kjerrström; Reinhold Benthin; E Lucht; Jun Fukushima; S Schwartz; Kenji Okuda; Britta Wahren; Jorma Hinkula
DNA-plasmids of HIV-1 induce systemic and mucosal immune responses.
Biological chemistry 1999;380(3):375-9.
1999: H Ghebrekidan; Ulla Rudén; S Cox; Britta Wahren; M Grandien
Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 1999;12(1):53-64.
1998: E L Ståhle; Lottie Schloss; Vivi-Anne Sundqvist; Maria Brytting; I Hökeberg; S Cox; Britta Wahren; Annika Linde
Solid phase ELISA for determination of the virus dose dependent sensitivity of human cytomegalovirus to antiviral drugs in vitro.
Antiviral research 1998;40(1-2):105-12.
1998: Benita Zweygberg Wirgart; Maria Brytting; Annika Linde; Britta Wahren; Lena Grillner
Sequence variation within three important cytomegalovirus gene regions in isolates from four different patient populations.
Journal of clinical microbiology 1998;36(12):3662-9.
1998: Göran Bratt; A Karlsson; Ann-Charlotte Boström; Jan Albert; Britta Wahren; Eric Sandström
Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.
AIDS (London, England) 1998;12(16):2193-202.
1998: P Putkonen; M Quesada-Rolander; Ann-Charlotte Boström; S Schwartz; Rigmor Thorstensson; Kenji Okuda; Britta Wahren; Jorma Hinkula
Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts.
Virology 1998;250(2):293-301.
1998: Peter Lundholm; E Lucht; E Svedmyr; Ulla Rudén; Annika Linde; Britta Wahren
Immunoglobulin G abnormalities in HIV-1 infected individuals with lymphoma.
Immunotechnology : an international journal of immunological engineering 1998;4(1):29-36.
1998: Göran Bratt; Ann-Charlotte Boström; Jan Albert; Eric Sandström; Britta Wahren
MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
AIDS (London, England) 1998;12(7):729-36.
1998: SA Calarota; Göran Bratt; S Nordlund; Jorma Hinkula; Ann-Charlotte Boström; Eric Sandström; Britta Wahren
Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.
Lancet 1998;351(9112):1320-5.
1998: Maria G Isaguliants; Y P Kadoshnikov; TI Kalinina; Valerii D Smirnov; Britta Wahren
Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Biochemistry. Biokhimii͡a 1998;63(5):551-8.
1998: Ingo Drexler; K Heller; Britta Wahren; Volker Erfle; Gerd Sutter
Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells.
The Journal of general virology 1998;79 ( Pt 2)():347-52.
1998: Ann-Charlotte Boström; Göran Bratt; Jorma Hinkula; G Gilljam; P Cochaux; M Samson; Eric Sandström; Britta Wahren
Induction of specific T-cell responses in HIV infection.
AIDS (London, England) 1998;12(2):157-66.
1998: H Ghebrekidan; S Cox; Britta Wahren; M Grandien
Prevalence of infection with HIV, hepatitis B and C viruses, in four high risk groups in Eritrea.
Clinical and diagnostic virology 1998;9(1):29-35.
1997: Y Asakura; Jorma Hinkula; Ann-Charlotte Boström; Jun Fukushima; Kenji Okuda; Britta Wahren
Induction of HIV-1 specific mucosal immune responses by DNA vaccination.
Scandinavian journal of immunology 1997;46(4):326-30.
1997: Eiichi Okada; Shin Sasaki; Norihisa Ishii; I Aoki; T Yasuda; K Nishioka; Jun Fukushima; J Miyazaki; Britta Wahren; Kenji Okuda
Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(7):3638-47.
1997: Britta Wahren; Maria Brytting
DNA increases the potency of vaccination against infectious diseases.
Current opinion in chemical biology 1997;1(2):183-9.
1997: Jorma Hinkula; C Svanholm; S Schwartz; Peter Lundholm; M Brytting; Gunnel Engström; Reinhold Benthin; H Glaser; Gerd Sutter; B Kohleisen; Volker Erfle; Kenji Okuda; Hans Wigzell; Britta Wahren
Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes.
Journal of virology 1997;71(7):5528-39.
1997: Jorma Hinkula; Peter Lundholm; Britta Wahren
Nucleic acid vaccination with HIV regulatory genes: a combination of HIV-1 genes in separate plasmids induces strong immune responses.
Vaccine 1997;15(8):874-8.
1996: Kristina Broliden; A Von Gegerfelt; C Persson; Peter Horal; Bo Svennerholm; Britta Wahren; Ewa Björling; A Vahlne
Identification of cross-reactive antigenic target regions for HIV type 1-specific antibody-dependent cellular cytotoxicity.
AIDS research and human retroviruses 1996;12(18):1699-702.
1996: Kristina Broliden; Jorma Hinkula; Göran Bratt; C Persson; A Otero; A Ekström; Eric Sandström; P A Broliden; Britta Wahren
Analyses of functional antibody responses in HIV-1-infected individuals after vaccination with rgp160.
Clinical and diagnostic virology 1996;6(2-3):115-26.
1996: M G Isaguliants; S Nordlund; Matti Sällberg; Valerii D Smirnov; U Rudén; Britta Wahren
HIV-1 epitopes exposed by hybrid hepatitis B core particles affect proliferation of peripheral blood mononuclear cells from HIV-1 positive donors.
Immunology letters 1996;52(1):37-44.
1996: M G Isaruliants; U Ruden; Britta Wahren
[Composition of HIV-1 B-epitopes and heterologous T-cell epitopes. II. Combined analysis of immunogenicity of composite peptides in rabbits].
Biokhimii͡a (Moscow, Russia) 1996;61(7):1230-40.
1996: M Levi; U Rudén; Britta Wahren
Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies.
Clinical and diagnostic laboratory immunology 1996;3(3):265-9.
1996: M G Isaguliants; Iu P Kadoshnikov; TI Kalinina; Iu E Khuliakov; IuA Semiletov; Valerii D Smirnov; Britta Wahren
[Expression of HIV-1 epitopes included in particles formed by human hepatitis B virus nucleocapsid protein].
Biokhimii͡a (Moscow, Russia) 1996;61(3):532-45.
1996: Britta Wahren; Maria Brytting; G Engström; Jorma Hinkula; M Levi; E L Ståhle; S Ohlsson; U Rudén; S Schwartz
Immune responses to the HIV rev regulatory gene.
Antibiotics and chemotherapy 1996;48():105-12.
1995: Britta Wahren; Jorma Hinkula; E L Ståhle; C A Borrebaeck; S Schwartz; Hans Wigzell
Nucleic acid vaccination with HIV regulatory genes.
Annals of the New York Academy of Sciences 1995;772():278-81.
1995: G Edevåg; Britta Wahren; A D Osterhaus; V A Sundqvist; M Granström
Enzyme-linked immunosorbent assay-based inhibition test for neutralizing antibodies to polioviruses as an alternative to the neutralization test in tissue culture.
Journal of clinical microbiology 1995;33(11):2927-30.
1995: F Wang; Maria Brytting; Göran Bratt; P Ljungman; Britta Wahren
Continuous detection of CMV DNA in plasma of patients with advanced HIV infection implies the poorest prognosis.
Clinical and diagnostic virology 1995;3(4):371-5.
1995: L T Chin; A C Malmborg; K Kristensson; Jorma Hinkula; Britta Wahren; Carl A K Borrebaeck
Mimicking the humoral immune response in vitro results in antigen-specific isotype switching supported by specific autologous T helper cells: generation of human HIV-1-neutralizing IgG monoclonal antibodies from naive donors.
European journal of immunology 1995;25(3):657-63.
1995: L T Chin; M Dueñas; M Levi; Jorma Hinkula; Britta Wahren; Carl A K Borrebaeck
Molecular characterization of a human anti-HIV 1 monoclonal antibody revealed a CD26-related motif in CDR2.
Immunology letters 1995;44(1):25-30.
1994: L T Chin; P Ifversen; K Kristensson; Britta Wahren; Roland Carlsson; Carl A K Borrebaeck
Human Th0-type T helper-cell clone supports antigen-specific immunoglobulin production in scid/beige-hu mice.
Scandinavian journal of immunology 1994;40(5):529-34.
1994: M Isaguliants; U Rudén; G Gilljam; Britta Wahren
Immunogenic combinations of HIV-1 B- and heterologous T-cell epitopes.
Immunology letters 1994;42(3):173-8.
1994: Jorma Hinkula; Magnus Gidlund; C Persson; A Osterhaus; Britta Wahren
Enzyme immunoassay (ELISA) for the evaluation of antibodies directed to the CD4 receptor-binding site of the HIV gp120 molecule.
Journal of immunological methods 1994;175(1):37-46.
1994: Jorma Hinkula; Göran Bratt; G Gilljam; S Nordlund; P A Broliden; V Holmberg; E Olausson-Hansson; Jan Albert; Eric Sandström; Britta Wahren
Immunological and virological interactions in patients receiving passive immunotherapy with HIV-1 neutralizing monoclonal antibodies.
Journal of acquired immune deficiency syndromes 1994;7(9):940-51.
1994: P Pushko; Matti Sällberg; Galina Borisova; U Ruden; V Bichko; Britta Wahren; Paul Pumpens; Lars O Magnius
Identification of hepatitis B virus core protein regions exposed or internalized at the surface of HBcAg particles by scanning with monoclonal antibodies.
Virology 1994;202(2):912-20.
1994: Peter Lundholm; M Wahren; Eric Sandström; F Volvovitz; Britta Wahren
Autoreactivity in HIV-infected individuals does not increase during vaccination with envelope rgp160.
Immunology letters 1994;41(2-3):147-53.
1994: M G Isaguliants; L L Sukhanova; M Levi; A P Bobkov; TI Kalinina; U Rudén; Valerii D Smirnov; Britta Wahren
Linear epitopes of HIV-1, presented as hybrids with Escherichia coli beta-galactosidase or synthetic peptides.
AIDS research and human retroviruses 1994;10(6):655-64.
1994: Matti Sällberg; P Pumpen; Z X Zhang; Peter Lundholm; I Gusars; U Rudén; Britta Wahren; Lars O Magnius
Locations of antibody binding sites within conserved regions of the hepatitis C virus core protein.
Journal of medical virology 1994;43(1):62-8.
1994: Marianne Jansson; Britta Wahren; Jan Albert; Gabriella Scarlatti; L Franzén; P K Kataaha; E Katabira; F Mubiro; Hans Wigzell; P Rossi
Peptide serology for analysis of the inter- and intra-individual variation in the HIV-1 V3 domain.
AIDS (London, England) 1994;8(4):413-21.
1994: Britta Wahren; Göran Bratt; C Persson; B Levén; Jorma Hinkula; G Gilljam; S Nordlund; L Eriksson; F Volvovitz; P A Broliden
Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160.
Journal of acquired immune deficiency syndromes 1994;7(3):220-9.
1994: L T Chin; Jorma Hinkula; M Levi; Mats Ohlin; Britta Wahren; Carl A K Borrebaeck
Site-directed primary in vitro immunization: production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors.
Immunology 1994;81(3):428-34.
1994: F Lolli; L B Chen; V A Sundqvist; H Link; V Holmberg; Britta Wahren
HIV antigen-reactive T cells detected by antigen-induced interferon gamma secretion.
AIDS research and human retroviruses 1994;10(2):115-20.
1994: Matti Sällberg; U Rudén; Britta Wahren; Lars O Magnius
Immune recognition of linear antigenic regions within the hepatitis B pre-C and C-gene translation products using synthetic peptides.
Journal of medical virology 1994;42(1):7-15.
1993: Paola Cinque; Maria Brytting; Luca Vago; Antonella Castagna; Carlo Parravicini; N Zanchetta; Antonella d'Arminio Monforte; Britta Wahren; Adriano Lazzarin; A Linde
Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.
Lancet 1993;342(8868):398-401.
1993: M Levi; U Rudén; Deborah L Birx; L Loomis; Robert R Redfield; K Lövgren; Lennart Akerblom; Eric Sandström; Britta Wahren
Effects of adjuvants and multiple antigen peptides on humoral and cellular immune responses to gp160 of HIV-1.
Journal of acquired immune deficiency syndromes 1993;6(8):855-64.
1993: Matti Sällberg; P Pushko; I Berzinsh; V Bichko; P Sillekens; M Noah; Paul Pumpens; Elmars Grens; Britta Wahren; Lars O Magnius
Immunochemical structure of the carboxy-terminal part of hepatitis B e antigen: identification of internal and surface-exposed sequences.
The Journal of general virology 1993;74 ( Pt 7)():1335-40.
1993: F Lolli; V A Sundqvist; Antonella Castagna; Per Ljungman; A Linde; G Andersson; T Olsson; Britta Wahren
T and B cell responses to cytomegalovirus antigens in healthy blood donors and bone marrow transplant recipients.
FEMS immunology and medical microbiology 1993;7(1):55-62.
1993: M Levi; Matti Sällberg; U Rudén; D Herlyn; H Maruyama; H Wigzell; J Marks; Britta Wahren
A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(10):4374-8.
1993: Matti Sällberg; U Rudén; Britta Wahren; Lars O Magnius
Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein.
Clinical and experimental immunology 1993;91(3):489-94.
1993: Mats Ohlin; V A Sundqvist; Michael Mach; Britta Wahren; Carl A K Borrebaeck
Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies.
Journal of virology 1993;67(2):703-10.
1993: Marianne Jansson; Britta Wahren; Gabriella Scarlatti; N Principi; V Lombardi; Susanna Livadiotti; L Elia; A Plebani; Hans Wigzell; P Rossi
Patterns of immunoglobulin G subclass reactivity to HIV-1 envelope peptides in children born to HIV-1 infected mothers.
AIDS (London, England) 1993;7(1):2nd page following p. 147.
1993: S W Cox; Jan Albert; E Ljungdahl-Ståhle; Britta Wahren
Effect of resistance on combination chemotherapy for human immunodeficiency virus infection.
Advances in enzyme regulation 1993;33():27-36.
1992: T Mathiesen; V P Collins; E Ohlsson; V A Sundqvist; Britta Wahren
Induction of MHC class I antigen expression following infection of a human esthesioneuroblastoma cell line with cytomegalovirus and human immunodeficiency virus.
Acta virologica 1992;36(6):551-6.
1992: E Ljungdahl-Ståhle; E Guzenda; D Böttiger; Britta Wahren; B Oberg; L Ståhle
Penetration of zidovudine and 3'-fluoro-3'-deoxythymidine into the brain, muscle tissue, and veins in cynomolgus monkeys: relation to antiviral action.
Antimicrobial agents and chemotherapy 1992;36(11):2418-22.
1992: V A Sundqvist; W Xu; Britta Wahren
Antibody responses to synthetic peptides from cytomegalovirus phosphoprotein 150.
Journal of clinical microbiology 1992;30(10):2735-9.
1992: Jan Albert; J Wahlberg; J Lundeberg; S Cox; Eric Sandström; Britta Wahren; M Uhlén
Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera.
Journal of virology 1992;66(9):5627-30.
1992: Matti Sällberg; U Rudén; Britta Wahren; Lars O Magnius
Immunodominant regions within the hepatitis C virus core and putative matrix proteins.
Journal of clinical microbiology 1992;30(8):1989-94.
1992: Mats Ohlin; Jorma Hinkula; P A Broliden; R Grunow; Carl A K Borrebaeck; Britta Wahren
Human MoAbs produced from normal, HIV-1-negative donors and specific for glycoprotein gp120 of the HIV-1 envelope.
Clinical and experimental immunology 1992;89(2):290-5.
1992: Maria Brytting; W Xu; Britta Wahren; V A Sundqvist
Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections.
Journal of clinical microbiology 1992;30(8):1937-41.
1992: S W Cox; Jan Albert; J Wahlberg; M Uhlén; Britta Wahren
Loss of synergistic response to combinations containing AZT in AZT-resistant HIV-1.
AIDS research and human retroviruses 1992;8(7):1229-34.
1992: Matti Sällberg; U Rudén; Britta Wahren; Lars O Magnius
Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: the isotypes and the recognition site.
Immunology letters 1992;33(1):27-33.
1992: Marianne Jansson; Britta Wahren; Gabriella Scarlatti; N Principi; V Lombardi; Susanna Livadiotti; L Elia; A Plebani; Hans Wigzell; P Rossi
Patterns of immunoglobulin G subclass reactivity to HIV-1 envelope peptides in children born to HIV-1-infected mothers.
AIDS (London, England) 1992;6(4):365-71.
1992: E Ljungdahl-Ståhle; J Trojnar; B Oberg; Britta Wahren
Early appearance of simian immunodeficiency virus (SIV) antigen and antibodies as variables in evaluating antiviral drugs in macaques.
Journal of virological methods 1992;37(1):43-53.
1992: Maria Brytting; J Wahlberg; J Lundeberg; Britta Wahren; M Uhlén; V A Sundqvist
Variations in the cytomegalovirus major immediate-early gene found by direct genomic sequencing.
Journal of clinical microbiology 1992;30(4):955-60.
1992: P A Broliden; A von Gegerfelt; P Clapham; J Rosen; Eva Maria Fenyö; Britta Wahren; Kristina Broliden
Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(2):461-5.
1992: M Mannervik; P Putkonen; U Rudén; K A Kent; E Norrby; Britta Wahren; P A Broliden
Identification of B-cell antigenic sites on HIV-2 gp125.
Journal of acquired immune deficiency syndromes 1992;5(2):177-87.
1992: T Mathiesen; C Brattström; J Andersson; A Linde; Per Ljungman; Britta Wahren
Immunoglobulin G subclasses and lymphocyte stimulatory responses to cytomegalovirus in transplant patients with primary cytomegalovirus infections.
Journal of medical virology 1992;36(1):65-9.
1991: M Silvestri; V A Sundqvist; U Rudén; Britta Wahren
Characterization of a major antigenic region on gp55 of human cytomegalovirus.
The Journal of general virology 1991;72 ( Pt 12)():3017-23.
1991: Matti Sällberg; U Rudén; Lars O Magnius; E Norrby; Britta Wahren
Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins.
Immunology letters 1991;30(1):59-68.
1991: P A Broliden; B Mäkitalo; Lennart Akerblom; J Rosen; Kristina Broliden; G Utter; Mikael Jondal; E Norrby; Britta Wahren
Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies.
Immunology 1991;73(4):371-6.
1991: C Orvell; Torsten Unge; Rama Bhikhabhai; Kristina Bäckbro; U Rudén; B Strandberg; Britta Wahren; Eva Maria Fenyö
Immunological characterization of the human immunodeficiency virus type 1 reverse transcriptase protein by the use of monoclonal antibodies.
The Journal of general virology 1991;72 ( Pt 8)():1913-8.
1991: Matti Sällberg; U Rudén; Britta Wahren; M Noah; Lars O Magnius
Human and murine B-cells recognize the HBeAg/beta (or HBe2) epitope as a linear determinant.
Molecular immunology 1991;28(7):719-26.
1991: E Fridell; B J Cohen; Britta Wahren
Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19.
Journal of clinical microbiology 1991;29(7):1376-81.
1991: Mats Ohlin; V A Sundqvist; G Gilljam; U Rudén; F O Gombert; Britta Wahren; Carl A K Borrebaeck
Characterization of human monoclonal antibodies directed against the pp65-kD matrix antigen of human cytomegalovirus.
Clinical and experimental immunology 1991;84(3):508-14.
1991: Maria Brytting; V A Sundqvist; Per Stålhandske; A Linde; Britta Wahren
Cytomegalovirus DNA detection of an immediate early protein gene with nested primer oligonucleotides.
Journal of virological methods 1991;32(2-3):127-38.
1991: E Fridell; J Trojnar; H Mehlin; Britta Wahren
A cyclized peptide for studies of human parvovirus B19 infection.
Journal of immunological methods 1991;138(1):125-8.
1991: Matti Sällberg; U Rudén; Lars O Magnius; H P Harthus; M Noah; Britta Wahren
Characterisation of a linear binding site for a monoclonal antibody to hepatitis B core antigen.
Journal of medical virology 1991;33(4):248-52.
1991: J Harmenberg; A Akesson-Johansson; A Gräslund; Torbjorn Malmfors; J Bergman; Britta Wahren; S Akerfeldt; L Lundblad; S Cox
The mechanism of action of the anti-herpes virus compound 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline.
Antiviral research 1991;15(3):193-204.
1991: B Lundgren; D Böttiger; E Ljungdahl-Ståhle; E Norrby; L Ståhle; Britta Wahren; B Oberg
Antiviral effects of 3'-fluorothymidine and 3'-azidothymidine in cynomolgus monkeys infected with simian immunodeficiency virus.
Journal of acquired immune deficiency syndromes 1991;4(5):489-98.
1991: Britta Wahren; Ulrika Harmenberg
Tumour markers in gastrointestinal cancer.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1991;206():21-7.
1991: Jorma Hinkula; G Gilljam; Britta Wahren
Production of a murine monoclonal antibody with anti-HIV-1 neutralizing properties.
Journal of clinical laboratory analysis 1991;5(6):399-405.
1991: Ulrika Harmenberg; E Ljungdahl-Ståhle; U Rudén; Britta Wahren
Search for epitopic sites of antibodies to germ cell alkaline phosphatase.
Cancer communications 1991;3(10-11):305-11.
1991: S Cox; R Koshida; J Harmenberg; Britta Wahren
Synergistic combinations and peptides in the inhibition of human immunodeficiency virus.
Advances in enzyme regulation 1991;31():85-97.
1991: P A Broliden; U Rudén; A S Ouattara; G de Thé; E Sølver; J Trojnar; Britta Wahren
Specific synthetic peptides for detection of and discrimination between HIV-1 and HIV-2 infection.
Journal of acquired immune deficiency syndromes 1991;4(10):952-8.
1991: Britta Wahren; A Linde
Virological and clinical characteristics of human herpesvirus 6.
Scandinavian journal of infectious diseases. Supplementum 1991;80():105-9.
1990: T Mathiesen; Anders Sönnerborg; J Trojnar; Britta Wahren
Fine analysis of intrathecally synthesized anti-HIV IgG1-4 by peptide mapping.
Journal of the neurological sciences 1990;100(1-2):31-6.
1990: A Akesson-Johansson; J Harmenberg; Britta Wahren; A Linde
Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds.
Antimicrobial agents and chemotherapy 1990;34(12):2417-9.
1990: E Brehmer-Andersson; E Ljungdahl-Ståhle; K Koshida; H Yamamoto; stigbrand torgny; Britta Wahren
Isoenzymes of alkaline phosphatases in seminomas. An immunohistochemical and biochemical study.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1990;98(11):977-82.
1990: S Cox; U Rudén; Karoly Nagy; Jan Albert; V Holmberg; Eric Sandström; Britta Wahren
Serum levels and catabolism of 3'-azido-3'-deoxythymidine in vivo measured using a specific radioimmunoassay.
Journal of virological methods 1990;30(1):89-98.
1990: H Dahl; A Linde; V A Sundqvist; Britta Wahren
An enzyme-linked immunosorbent assay for IgG antibodies to human herpes virus 6.
Journal of virological methods 1990;29(3):313-23.
1990: T Mathiesen; L Hammarström; E Fridell; A Linde; G Wirsen; C I Smith; E Norrby; Britta Wahren
Aberrant IgG subclass distribution to measles in healthy seropositive individuals, in patients with SSPE and in immunoglobulin-deficient patients.
Clinical and experimental immunology 1990;80(2):202-5.
1990: A Linde; B Kallin; Joakim Dillner; J Andersson; L Jägdahl; A Lindvall; Britta Wahren
Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis.
The Journal of infectious diseases 1990;161(5):903-9.
1990: Jorma Hinkula; J Rosen; V A Sundqvist; stigbrand torgny; Britta Wahren
Epitope mapping of the HIV-1 gag region with monoclonal antibodies.
Molecular immunology 1990;27(5):395-403.
1990: T Mathiesen; E Olding-Stenkvist; A Linde; O Olsson; Britta Wahren
Specific in vitro IgG subclass synthesis and lymphocyte proliferation responses in herpes virus encephalitis.
Acta neurologica Scandinavica 1990;81(4):341-5.
1990: K Ljunggren; Viviana Moschese; P A Broliden; C Giaquinto; I Quinti; Eva Maria Fenyö; Britta Wahren; P Rossi; Mikael Jondal
Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers.
The Journal of infectious diseases 1990;161(2):198-202.
1990: P A Broliden; K Ljunggren; Jorma Hinkula; E Norrby; Lennart Akerblom; Britta Wahren
A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization.
Journal of virology 1990;64(2):936-40.
1990: A Linde; E Fridell; H Dahl; J Andersson; P Biberfeld; Britta Wahren
Effect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers.
Journal of clinical microbiology 1990;28(2):211-5.
1990: K Koshida; Britta Wahren
Enzymatic heterogeneity of seminomas.
Clinica chimica acta; international journal of clinical chemistry 1990;186(2):255-64.
1990: K Koshida; stigbrand torgny; E Munck-Wikland; H Hisazumi; Britta Wahren
Analysis of serum placental alkaline phosphatase activity in testicular cancer and cigarette smokers.
Urological research 1990;18(3):169-73.
1989: R Koshida; S Cox; J Harmenberg; G Gilljam; Britta Wahren
Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1.
Antimicrobial agents and chemotherapy 1989;33(12):2083-8.
1989: V A Sundqvist; Jan Albert; E Ohlsson; Jorma Hinkula; Eva Maria Fenyö; Britta Wahren
Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics.
Journal of medical virology 1989;29(3):170-5.
1989: P A Broliden; Viviana Moschese; K Ljunggren; J Rosen; C Fundaro; A Plebani; Mikael Jondal; P Rossi; Britta Wahren
Diagnostic implication of specific immunoglobulin G patterns of children born to HIV-infected mothers.
AIDS (London, England) 1989;3(9):577-82.
1989: G Gilljam; Britta Wahren
Properties of IgG subclasses to human cytomegalovirus.
Journal of virological methods 1989;25(2):139-51.
1989: Francesca Chiodi; T Mathiesen; Jan Albert; E Parks; E Norrby; Britta Wahren
IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(11):3809-14.
1989: T Mathiesen; H von Holst; Sten Fredrikson; G Wirsén; B Hederstedt; E Norrby; V A Sundqvist; Britta Wahren
Total, anti-viral, and anti-myelin IgG subclass reactivity in inflammatory diseases of the central nervous system.
Journal of neurology 1989;236(4):238-42.
1989: T Mathiesen; A Linde; E Olding-Stenkvist; Britta Wahren
Antiviral IgM and IgG subclasses in varicella zoster associated neurological syndromes.
Journal of neurology, neurosurgery, and psychiatry 1989;52(5):578-82.
1989: R Koshida; L Vrang; G Gilljam; J Harmenberg; B Oberg; Britta Wahren
Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.
Antimicrobial agents and chemotherapy 1989;33(5):778-80.
1989: P A Broliden; L Morfeldt-Månsson; J Rosen; Mikael Jondal; Britta Wahren
Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
Clinical and experimental immunology 1989;76(2):216-21.
1989: T Mathiesen; Francesca Chiodi; P A Broliden; Jan Albert; R A Houghten; G Utter; Britta Wahren; E Norrby
Analysis of a subclass-restricted HIV-1 gp41 epitope by omission peptides.
Immunology 1989;67(1):1-7.
1989: Ulrika Harmenberg; Jan-Erik Frödin; E Ljungdahl-Stähle; Håkan Mellstedt; Britta Wahren; stigbrand torgny
Significance of alkaline phosphatase isozymes in the monitoring of patients with colorectal carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1989;10(5):225-31.
1989: K Koshida; stigbrand torgny; H Hisazumi; Britta Wahren
Electrophoretic heterogeneity of alkaline phosphatase isozymes in seminoma and normal testis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1989;10(4):181-9.
1989: K Koshida; stigbrand torgny; H Hisazumi; Britta Wahren
Hydrophobicity and lectin affinity of alkaline phosphatase isozymes in seminoma and normal testis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1989;10(4):173-80.
1989: E Fridell; J Trojnar; Britta Wahren
A new peptide for human parvovirus B19 antibody detection.
Scandinavian journal of infectious diseases 1989;21(6):597-603.
1989: Britta Wahren; J Rosen; Eric Sandström; T Mathiesen; S Modrow; H Wigzell
HIV-1 peptides induce a proliferative response in lymphocytes from infected persons.
Journal of acquired immune deficiency syndromes 1989;2(5):448-56.
1989: T Mathiesen; Anders Sönnerborg; Britta Wahren
Detection of antibodies against myelin basic protein and increased levels of HIV-IgG antibodies and HIV antigen after solubilization of immune complexes in sera and CSF of HIV infected patients.
Viral immunology 1989;2(1):1-9.
1988: T Mathiesen; V A Sundqvist; Jan Albert; E Ohlsson; Britta Wahren
Acid hydrolysis of serum samples to increase detection of HIV antigen.
Journal of virological methods 1988;22(2-3):143-8.
1988: J Harmenberg; Britta Wahren; J Bergman; S Akerfeldt; L Lundblad
Antiherpesvirus activity and mechanism of action of indolo-(2,3-b)quinoxaline and analogs.
Antimicrobial agents and chemotherapy 1988;32(11):1720-4.
1988: T Mathiesen; A Linde; E Olding-Stenkvist; Britta Wahren
Specific IgG subclass reactivity in herpes simplex encephalitis.
Journal of neurology 1988;235(7):400-6.
1988: K Ljunggren; P A Broliden; L Morfeldt-Månson; Mikael Jondal; Britta Wahren
IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages.
Clinical and experimental immunology 1988;73(3):343-7.
1988: A Linde; H Dahl; Britta Wahren; E Fridell; Z Salahuddin; P Biberfeld
IgG antibodies to human herpesvirus-6 in children and adults and in primary Epstein-Barr virus infections and cytomegalovirus infections [corrected].
Journal of virological methods 1988;21(1-4):117-23.
1988: Jan-Erik Frödin; Ulrika Harmenberg; P Biberfeld; B Christensson; Ann Kari Lefvert; A Rieger; Jayant D Shetye; Britta Wahren; Håkan Mellstedt
Clinical effects of monoclonal antibodies (MAb 17-1A) in patients with metastatic colorectal carcinomas.
Hybridoma 1988;7(4):309-21.
1988: G Abele; B Eriksson; J Harmenberg; Britta Wahren
Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate.
Antimicrobial agents and chemotherapy 1988;32(8):1137-42.
1988: Britta Wahren; Francesca Chiodi; K Ljunggren; S Putney; R Kurth; Robert C Gallo; Eva Maria Fenyö
B and T cell reactivities after immunization of macaques with HIV subcomponents.
AIDS research and human retroviruses 1988;4(3):199-210.
1988: T Mathiesen; M A Persson; V A Sundqvist; Britta Wahren
Neutralization capacity and antibody dependent cell-mediated cytotoxicity of separated IgG subclasses 1, 3 and 4 against herpes simplex virus.
Clinical and experimental immunology 1988;72(2):211-5.
1988: T Mathiesen; E Fridell; Sten Fredrikson; A Linde; V A Sundqvist; D Edler; Britta Wahren
Combination ELISAs for antiviral antibodies in CSF and serum in patients with neurological symptoms and in healthy controls.
Journal of virological methods 1988;19(2):169-79.
1988: A Linde; V A Sundqvist; T Mathiesen; Britta Wahren
IgG subclasses to subviral components.
Monographs in allergy 1988;23():27-32.
1988: H Yamamoto; U Rudén; P Esposti; K Hirano; stigbrand torgny; L Andersson; H Hisazumi; Britta Wahren
Profiles of epitope-defined markers in sera from patients with testicular germ cell tumors.
Urological research 1988;16(1):31-6.
1987: H Yamamoto; U Rudén; E Ljungdahl-Ståhle; E Brehmer-Andersson; K Hirano; H Hisazumi; stigbrand torgny; Britta Wahren
Patterns of seminoma tissue markers and deletions.
International journal of cancer. Journal international du cancer 1987;40(5):615-9.
1987: G Abele; A Karlström; J Harmenberg; S Shigeta; A Larsson; B Lindborg; Britta Wahren
Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture.
Antimicrobial agents and chemotherapy 1987;31(1):76-80.
1986: A Akesson-Johansson; J O Lernestedt; O Ringdén; B Lönnqvist; Britta Wahren
Sensitivity of cytomegalovirus to intravenous foscarnet treatment.
Bone marrow transplantation 1986;1(2):215-20.
1986: J Harmenberg; V A Sundqvist; H Gadler; B Levén; G Brännström; Britta Wahren
Comparative methods for detection of thymidine kinase-deficient herpes simplex virus type 1 strains.
Antimicrobial agents and chemotherapy 1986;30(4):570-3.
1986: Olle Ringdén; T Paulin; V A Sundqvist; Britta Wahren; P Pihlstedt
Induction of immunoglobulin secretion and DNA synthesis in human lymphocytes in vitro by cytomegalovirus preparations.
Scandinavian journal of immunology 1986;24(3):273-81.
1986: E Ljungdahl-Ståhle; Ulrika Harmenberg; U Rudén; S Hammarström; stigbrand torgny; Britta Wahren
Improved radioimmunolocalization of carcinomas using Fab fragments with anti-CEA specificity.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1986;7(5-6):353-60.
1986: Britta Wahren; S Hammarström; Ulrika Harmenberg; S von Krusenstierna; S A Larsson; G Lundell; U Rudén; P O Schnell
Polyclonal and monoclonal anti-CEA antibodies in immunolocalization of colorectal cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1986;7(5-6):361-9.
1985: J Harmenberg; Britta Wahren; V A Sundqvist; B Levén
Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds.
The Journal of antimicrobial chemotherapy 1985;15(5):567-73.
1985: J Harmenberg; G Abele; Britta Wahren
Nucleoside pools of acyclovir-treated herpes simplex type 1 infected cells.
Antiviral research 1985;5(2):75-81.
1985: G Gilljam; V A Sundqvist; A Linde; P Pihlstedt; A E Eklund; Britta Wahren
Sensitive analytic ELISAs for subclass herpes virus IgG.
Journal of virological methods 1985;10(3):203-14.
1984: Olle Ringdén; T Paulin; P Pihlstedt; B Lönnqvist; Britta Wahren
Cytomegalovirus antibody screening of blood donors for immunocompromised seronegative patients.
Lancet 1984;2(8410):1044.
1983: Britta Wahren; P Wahren; J Harmenberg; V A Sundqvist
Computer-based virus sensitivity assay and neutralization method. Applications for herpesviruses.
Journal of virological methods 1983;6(5):271-82.
1983: Britta Wahren; J Harmenberg; V A Sundqvist; B Levén; B Sköldenberg
A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds.
Journal of virological methods 1983;6(3):141-9.